Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bridging anticoagulation].

S M Schellong1, K Halbritter, S Haas

  • 1Arbeitsbereich Angiologie, Medizinische Klinik III, Universitätsklinikum Carl Gustav Carus,Technische Universität Dresden, Fetscherstrasse 74, 01307 Dresden. sebastian.schellong@uniklinikum-dresden.de

Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|January 26, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Are there any male-to-female disparities in recurrence rates after surgery for Pilonidal Disease? A meta-analysis comparing differing mixed-gender cohorts].

Khirurgiia·2026
Same author

Chronic inflammatory demyelinating polyneuropathy (CIDP) after cilta-cel therapy.

Blood cancer journal·2025
Same author

Gender-specific outcomes in pilonidal sinus disease: Female outcomes after cleft lift surgery in a large prospective Danish cohort.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2025
Same author

Long-term outcomes after cleft lift surgery for pilonidal sinus disease in post-pubertal adolescents: data from a prospective Danish cohort.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2024
Same author

The new small-angle X-ray scattering beamline for materials research at PETRA III: SAXSMAT beamline P62.

Journal of synchrotron radiation·2023
Same author

Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212).

ESMO open·2023
Same journal

[S3 Guideline "Adult soft tissue sarcomas"].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Synopsis-S3 guidelines pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Laparoscopic sentinel node navigation surgery in gastric cancer to reduce surgical radicality].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[ASCO guidelines for the treatment of stage III NSCLC part 4: indications for adjuvant therapy].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Surgical treatment of pancreatic cancer-What is new?]

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
See all related articles

Patients needing surgery while on blood thinners (vitamin K antagonists) require bridging anticoagulation. Low molecular weight heparins are recommended for this bridging therapy due to their safety and efficacy.

Area of Science:

  • Medical Science
  • Pharmacology
  • Clinical Practice

Background:

  • Patients on vitamin K antagonist anticoagulation often require invasive procedures.
  • Interruption of anticoagulation increases the risk of thromboembolism.
  • Bridging anticoagulation with shorter-acting agents is necessary to mitigate this risk.

Purpose of the Study:

  • To review the risks of thromboembolism and major bleeding during bridging anticoagulation.
  • To evaluate the suitability of low molecular weight heparins for bridging therapy.
  • To provide guidance for safe bridging anticoagulation management.

Main Methods:

  • Review of existing literature and large patient cohort studies.
  • Analysis of efficacy and safety data for different anticoagulant agents.

Related Experiment Videos

  • Development of a simple dosing scheme for low molecular weight heparins.

    • Main Results:

    • Low molecular weight heparins are a practical choice for bridging anticoagulation.
    • These agents offer a favorable risk-benefit profile compared to unfractionated heparin.
    • Outpatient management is feasible due to lack of monitoring requirements.

    Conclusions:

    • Low molecular weight heparins demonstrate solid evidence for efficacy and safety in bridging anticoagulation.
    • Despite not being formally labeled for this indication, they are the preferred option.
    • Safe management protocols are essential for patients undergoing bridging anticoagulation.